Juruena MF - Search Results

1

Improved stress response in bipolar affective disorder with adjunctive spironolactone (mineralocorticoid receptor antagonist): case series.

Juruena MF, Gama CS, Berk M, Belmonte-de-Abreu PS. Juruena MF, et al. J Psychopharmacol. 2009 Nov;23(8):985-7. doi: 10.1177/0269881108092121. Epub 2008 Jun 26. J Psychopharmacol. 2009. PMID: 18583441

2

The Association of Biochemical and Genetic Biomarkers in VEGF Pathway with Depression.

Nunes FDD, Ferezin LP, Pereira SC, Figaro-Drumond FV, Pinheiro LC, Menezes IC, Baes CVW, Coeli-Lacchini FB, Tanus-Santos JE, Juruena MF, Lacchini R. Nunes FDD, et al. Among authors: juruena mf. Pharmaceutics. 2022 Dec 9;14(12):2757. doi: 10.3390/pharmaceutics14122757. Pharmaceutics. 2022. PMID: 36559251 Free PMC article.

3

[The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression].

Juruena MF, Cleare AJ, Pariante CM. Juruena MF, et al. Braz J Psychiatry. 2004 Sep;26(3):189-201. doi: 10.1590/s1516-44462004000300009. Epub 2004 Nov 17. Braz J Psychiatry. 2004. PMID: 15645065 Free article. Review. Portuguese.

4

Different responses to dexamethasone and prednisolone in the same depressed patients.

Juruena MF, Cleare AJ, Papadopoulos AS, Poon L, Lightman S, Pariante CM. Juruena MF, et al. Psychopharmacology (Berl). 2006 Dec;189(2):225-35. doi: 10.1007/s00213-006-0555-4. Epub 2006 Oct 3. Psychopharmacology (Berl). 2006. PMID: 17016711 Clinical Trial.

5

Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.

Juruena MF, Ottoni GL, Machado-Vieira R, Carneiro RM, Weingarthner N, Marquardt AR, Fleig SS, Broilo L, Busnello EA. Juruena MF, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):94-9. doi: 10.1016/j.pnpbp.2008.10.012. Epub 2008 Oct 31. Prog Neuropsychopharmacol Biol Psychiatry. 2009. PMID: 19007842 Clinical Trial.

6

Prednisolone suppression test in depression: prospective study of the role of HPA axis dysfunction in treatment resistance.

Juruena MF, Pariante CM, Papadopoulos AS, Poon L, Lightman S, Cleare AJ. Juruena MF, et al. Br J Psychiatry. 2009 Apr;194(4):342-9. doi: 10.1192/bjp.bp.108.050278. Br J Psychiatry. 2009. PMID: 19336786

7

The role of mineralocorticoid receptor function in treatment-resistant depression.

Juruena MF, Pariante CM, Papadopoulos AS, Poon L, Lightman S, Cleare AJ. Juruena MF, et al. J Psychopharmacol. 2013 Dec;27(12):1169-79. doi: 10.1177/0269881113499205. Epub 2013 Jul 31. J Psychopharmacol. 2013. PMID: 23904409 Clinical Trial.

8

Early-life stress and HPA axis trigger recurrent adulthood depression.

Juruena MF. Juruena MF. Epilepsy Behav. 2014 Sep;38:148-59. doi: 10.1016/j.yebeh.2013.10.020. Epub 2013 Nov 20. Epilepsy Behav. 2014. PMID: 24269030 Review.

9

Bipolar affective disorder and borderline personality disorder: Differentiation based on the history of early life stress and psychoneuroendocrine measures.

Mazer AK, Cleare AJ, Young AH, Juruena MF. Mazer AK, et al. Among authors: juruena mf. Behav Brain Res. 2019 Jan 14;357-358:48-56. doi: 10.1016/j.bbr.2018.04.015. Epub 2018 Apr 24. Behav Brain Res. 2019. PMID: 29702176

10

Has the sun set for seasonal affective disorder and HPA axis studies? A systematic review and future prospects.

Agustini B, Bocharova M, Walker AJ, Berk M, Young AH, Juruena MF. Agustini B, et al. Among authors: juruena mf. J Affect Disord. 2019 Sep 1;256:584-593. doi: 10.1016/j.jad.2019.06.060. Epub 2019 Jul 2. J Affect Disord. 2019. PMID: 31299439

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

89 results

Search Page